关键利益相关者对北克社区药房提供疫苗接种服务的看法
Alexandre Chadi1, Daniel J G Thirion1,2, Nancy M Waite3
1Faculty of Pharmacy, Montreal University, Montreal, Quebec.
概括
组织和技术障碍阻碍药剂师为服务不足的人群接种疫苗. 提高激励和系统集成对于药剂师积极接触这些社区至关重要.
科学领域:
- 公共卫生 公共卫生
- 药房实践 在药房实践.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 疫苗接种不足是一个重大的公共卫生问题,不成比例地影响着服务不足的人口.
- 作为可访问的医疗保健专业人员,药剂师处于独特的位置,可以提高社区内的疫苗接种率.
研究的目的:
- 调查影响药剂师解决社区药房设置中服务不足客户的疫苗接种需求的能力的组织障碍.
主要方法:
- 与北克14个主要利益相关者进行了半结构化采访,包括药房协会,连锁店,卫生中心和公共卫生部门.
- 采访结果编码使用来自实施研究综合框架的领域.
主要成果:
- 在四个关键领域确定了障碍:疫苗服务物流,药房环境,外部影响和药剂师的知识/信念.
- 技术整合问题 (药房软件,疫苗注册表,预约系统) 限制了服务不足的人群的访问.
- 激励措施不支持难以接触的客户主动接种疫苗,旅行健康等专业服务会产生抵抗力.
结论:
- 药剂师有很好的地位,可以提高疫苗接种率,但在为服务不足的社区服务时面临技术和组织挑战.
- 建议包括将激励措施与主动推广相协调,以鼓励药剂师识别和接触服务不足的人群.
相关概念视频
Primary Healthcare Services
1.3K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.3K
Pharmacovigilance
774
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
774
Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Pharmacokinetics: Overview
5.6K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
5.6K
Drug Delivery: Parenteral Route
425
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
425
Pharmacokinetic Models: Overview
592
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
592


